3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia-Reference-Cited by-同舟云学术

3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

Published:2018-02-02 Issue:4 Volume:57 Page:561-568
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Sanders Donald B.¹,Juel Vern C.¹,Harati Yadollah²,Smith A. Gordon³,Peltier Amanda C.⁴,Marburger Tessa⁵,Lou Jau‐Shin⁶,Pascuzzi Robert M.⁷,Richman David P.⁸,Xie Tai⁹,Demmel Valentin¹⁰,Jacobus Laura R.¹¹,Aleš Kathy L.¹¹,Jacobus David P.¹¹,

Affiliation:

1. Department of NeurologyDuke University Medical Center, Box 3403Durham North Carolina27710 USA

2. Department of NeurologyBaylor College of MedicineHouston Texas USA

3. Department of NeurologyUniversity of Utah School of MedicineSalt Lake City Utah USA

4. Department of NeurologyVanderbilt Medical CenterNashville Tennessee USA

5. Department of Neurology, Oregon Health and Science UniversityPortland Oregon USA

6. Department of NeurologyUniversity of North Dakota School of Medicine & Health ScienceFargo North Dakota USA

7. Department of NeurologyIndiana UniversityIndianapolis Indiana USA

8. Department of Neurology, Center for NeuroscienceUniversity of CaliforniaDavis, Davis California USA

9. Brightech International LLCSomerset New Jersey USA

10. nabios GMBHMunich Germany

11. Jacobus Pharmaceutical CompanyPrinceton New Jersey

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.26052

Reference19 articles.

1. Myasthenia gravis and myasthenic disorders 2015 Oxford University Press Oxford United Kingdom VC Juel DB Sanders AG Engel Lambert‐Eaton myasthenic syndrome 156 172

2. The edipemiology of neuromuscular disorders: a comprehensive overview of the literature;Deenen JCW;J Neuromuscular Dis,2015

3. Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population

4. The Role of Autoantibodies in Lambert-Eaton Myasthenic Syndromeaa

5. Novel drug of choice in Eaton-Lambert syndrome.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postexercise reflex facilitation in Lambert-Eaton myasthenic syndrome;Practical Neurology;2024-01-30

2. Amifampridines are the Most Effective Drugs for Treating Lambert-Eaton Myasthenic Syndrome With a Focus on Pediatric Lambert-Eaton Myasthenic Syndrome;Journal of Clinical Neurology;2024

3. Clinical, Pathophysiological and Electrodiagnostic Aspects of Lambert-Eaton Myasthenic Syndrome;Topics in Autonomic Nervous System;2023-11-02

4. Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects;Journal of Neurophysiology;2023-05-01

5. An Efficient Undergraduate Synthesis of the Exorbitantly Priced Lambert–Eaton Myasthenic Syndrome Drug Amifampridine;Journal of Chemical Education;2023-01-31